3.5 COT extract and CEL treatment inhibited HFD-induced increase in lipid levels possibly via regulating FGF21/AMPK/PGC-1α axis in the liver tissue of NAFLD mice. The gene discussed is PPARGC1A; the disease is metabolic dysfunction-associated steatotic liver disease.